» Articles » PMID: 29581886

TRIM29 Negatively Controls Antiviral Immune Response Through Targeting STING for Degradation

Overview
Journal Cell Discov
Date 2018 Mar 28
PMID 29581886
Citations 63
Authors
Affiliations
Soon will be listed here.
Abstract

Innate immune system is armed by several lines of pattern recognition receptors to sense various viral infection and to initiate antiviral immune response. This process is under a tight control and the negative feedback induced by infection and/or inflammation is critical to maintain immune homoeostasis and to prevent autoimmune disorders, however, the molecular mechanism is not fully understood. Here we report TRIM29, a ubiquitin E3 ligase, functions as an inducible negative regulator of innate immune response triggered by DNA virus and cytosolic DNA. DNA virus and cytosolic DNA stimulation induce TRIM29 expression robustly in macrophages and dendritic cells, although the basal level of TRIM29 is undetectable in those cells. TRIM29 deficiency elevates IFN-I and proinflammatory cytokine production upon viral DNA and cytosolic dsDNA stimulation. Consistently, in vivo experiments show that TRIM29-deficient mice are more resistant to HSV-1 infection than WT controls, indicated by better survival rate and reduced viral load in organs. Mechanism studies suggest that STING-TBK1-IRF3 signaling pathway in TRIM29 KO cells is significantly enhanced and the degradation of STING is impaired. Furthermore, we identify that TRIM29 targets STING for K48 ubiquitination and degradation. This study reveals TRIM29 as a crucial negative regulator in immune response to DNA virus and cytosolic DNA, preventing potential damage caused by overcommitted immune responses.

Citing Articles

Implications of tissue specific STING protein flux and abundance on inflammation and the development of targeted therapeutics.

Angel T, Chen Z, Moghieb A, Ng S, Beal A, Capriotti C PLoS One. 2025; 20(2):e0319216.

PMID: 39999142 PMC: 11856325. DOI: 10.1371/journal.pone.0319216.


TRIM29 reverses lenvatinib resistance in liver cancer cells by ubiquitinating and degrading YBX1 to inhibit the PI3K/AKT pathway.

Tang Y, Fan S, Peng R, Liu H, Su B, Tu D Transl Oncol. 2025; 53:102294.

PMID: 39874728 PMC: 11810836. DOI: 10.1016/j.tranon.2025.102294.


A20 as a Potential Therapeutic Target for COVID-19.

Wu Y, He L, Li R, Li J, Zhao Q, Shao B Immun Inflamm Dis. 2025; 13(1):e70127.

PMID: 39853876 PMC: 11760982. DOI: 10.1002/iid3.70127.


The Role and Mechanism of TRIM Proteins in Gastric Cancer.

Wu W, Yang J, Yu T, Zou Z, Huang X Cells. 2025; 13(24.

PMID: 39768197 PMC: 11674240. DOI: 10.3390/cells13242107.


TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyond.

Wu Q, Nandi D, Sharma D Cancer Metastasis Rev. 2024; 44(1):16.

PMID: 39644332 PMC: 11625080. DOI: 10.1007/s10555-024-10226-2.


References
1.
Kim M, Hwang S, Imaizumi T, Yoo J . Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol. 2007; 82(3):1474-83. PMC: 2224411. DOI: 10.1128/JVI.01650-07. View

2.
Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H . A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408(6813):740-5. DOI: 10.1038/35047123. View

3.
Hu H, Brittain G, Chang J, Puebla-Osorio N, Jin J, Zal A . OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3. Nature. 2013; 494(7437):371-4. PMC: 3578967. DOI: 10.1038/nature11831. View

4.
Hu H, Wang H, Xiao Y, Jin J, Chang J, Zou Q . Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J Exp Med. 2016; 213(3):399-414. PMC: 4813674. DOI: 10.1084/jem.20151426. View

5.
Chiu Y, MacMillan J, Chen Z . RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell. 2009; 138(3):576-91. PMC: 2747301. DOI: 10.1016/j.cell.2009.06.015. View